Q Code

All Codes   A Code   B Code   C Code   CPT Code   J Code   NOC Code   P Code   Q Code   S Code

TENIPOSIDE – Q2017

TENIPOSIDE is an Oncology drug manufactured by WG Critical Care and administered via the Intravenous route of administration. The Q Code: Q2017 is aligned to the drug TENIPOSIDE.

read more

ACTEMRA – Q0249

ACTEMRA is a COVID-19 drug manufactured by Genentech and administered via the Intravenous route of administration. The Q Code: Q0249 is aligned to the drug ACTEMRA.

read more

Sotrovimab Injection – Q0247

Sotrovimab Injection is a COVID-19 drug manufactured by GSK and administered via the Intravenous route of administration. The Q Code: Q0247 is aligned to the drug Sotrovimab Injection.

read more

OGIVRI – Q5114

OGIVRI is an Oncology Biosimilar drug manufactured by Mylan and administered via the Intravenous route of administration. The Q Code: Q5114 is aligned to the drug OGIVRI.

read more

Apligraf Disk – Q4101

Apligraf Disk is a Wound Care drug manufactured by Organogenesis and administered via the Topical application route of administration. The Q Code: Q4101 is aligned to the drug Apligraf Disk.

read more

HERZUMA – Q5113

HERZUMA is an Oncology Biosimilar drug manufactured by Teva and administered via the Intravenous route of administration. The Q Code: Q5113 is aligned to the drug HERZUMA.

read more

EPOGEN – Q4081

EPOGEN is an Oncology drug manufactured by Amgen and administered via the Intravenous route of administration. The Q Code: Q4081 is aligned to the drug EPOGEN.

read more

ONTRUZANT – Q5112

ONTRUZANT is an Oncology Biosimilar drug manufactured by Merck and administered via the Intravenous route of administration. The Q Code: Q5112 is aligned to the drug ONTRUZANT.

read more

UDENYCA – Q5111

UDENYCA is an Oncology Biosimilar Colony Stimulating Factor drug manufactured by Coherus Biosciences Inc and administered via the Subcutaneous route of administration. The Q Code: Q5111 is aligned to the drug UDENYCA.

read more

NIVESTYM – Q5110

NIVESTYM is an Oncology Biosimilar Colony Stimulating Factor drug manufactured by Pfizer and administered via the Injection route of administration. The Q Code: Q5110 is aligned to the drug NIVESTYM.

read more

FULPHILA – Q5108

FULPHILA is an Oncology Biosimilar Colony Stimulating Factor drug manufactured by Mylan and administered via the Subcutaneous route of administration. The Q Code: Q5108 is aligned to the drug FULPHILA.

read more

MVASI – Q5107

MVASI is an Oncology Biosimilar drug manufactured by Amgen and administered via the Intravenous route of administration. The Q Code: Q5107 is aligned to the drug MVASI.

read more